<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>EMUC25</provider_name><provider_url>https://emuc.org</provider_url><author_name>Loek Keizer</author_name><author_url>https://emuc.org/author/loek/</author_url><title>The future of good evidence gathering for PCa - EMUC25</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="dU8CBhpzn5"&gt;&lt;a href="https://emuc.org/future-good-evidence-gathering-pca/"&gt;The future of good evidence gathering for PCa&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://emuc.org/future-good-evidence-gathering-pca/embed/#?secret=dU8CBhpzn5" width="600" height="338" title="&#x201C;The future of good evidence gathering for PCa&#x201D; &#x2014; EMUC25" data-secret="dU8CBhpzn5" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://emuc.org/wp-content/uploads/2025/02/EMUC25-Social-media-image.png</thumbnail_url><thumbnail_width>1200</thumbnail_width><thumbnail_height>630</thumbnail_height><description>New approaches to clinical trials can lead to more successful results in the challenging near future. Parallel, comparative studies and a better selection of patients are just some positive developments in the generation of useful evidence for prostate cancer treatment, according to Dr. Laurence Collette (Brussels, BE). Dr. Collette spoke as part of the Friday morning session on prostate cancer [&hellip;]</description></oembed>
